GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ABCB · Sep 30, 2024

Ameris Bancorp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000351569-24-000039Bank
Sequential deposit growth40thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

2.03% · CORE · VALID

Net-income growth65thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

23.84% · CORE · VALID

Interest-income growth30thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

7.44% · CORE · VALID

Cash and equivalents50thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$1.4B · CORE · VALID

Sequential loan growth15thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

-0.13% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History52 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Decreased
Previous
2.13%
Current
2.03%
Delta
-0.10%
Earnings Growth Decreased
Previous
44.94%
Current
23.84%
Delta
-21.11%
Interest Income Growth Decreased
Previous
7.88%
Current
7.44%
Delta
-0.44%
Liquidity Decreased
Previous
$1.4B
Current
$1.4B
Delta
-$3.0M
Loan Growth Decreased
Previous
1.85%
Current
-0.13%
Delta
-1.98%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.